Helms TH, Mullins RD, Thomas-Ahner JM, Kulp SK, Campbell MJ, Lucas F, et al
Hydration: GLP-1s can reduce your thirst signal
Survodutide Active Compound is the Fastest Growing Segment of the GLP-1 Market During the Forecast Period In terms of the active compound, the market is segmented into dulaglutide, liraglutide, orforglipron, retatrutide, semaglutide, survodutide, tirzepatide and other active compounds
Similar content being viewed by others Introduction Obesity, diabetes, and chronic kidney disease (CKD) are intricately interconnected, collectively exerting a profound impact on cardiovascular health and contributing to a complex state of cardiorenal metabolic dysregulation
The economic burden of obesity is also substantial, with increased healthcare costs and lost productivity